Literature DB >> 534518

Structure--activity relationship of inhibitors of hydroxyapatite formation.

G Williams, J D Sallis.   

Abstract

The relative abilities of some compounds to inhibit the transformation of amorphous calcium phosphate into hydroxyapatite were determined. Organic diphosphates, fructose 1,6-bisphosphate, pyrophosphate, imidodiphosphate and 3-phospholycerate all inhibited to various degrees. Strong inhibition was observed with phosphonoformate, and phosphocitrate proved to be the most powerful of the inhibitors examined. On the basis of these new findings an improved concept of the structure--activity relationship of inhibitors is proposed and mechanisms for inhibitor action are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 534518      PMCID: PMC1161691          DOI: 10.1042/bj1840181

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Inhibition of apatite formation by phosphorylated metabolites and macromolecules.

Authors:  J D Termine; K M Conn
Journal:  Calcif Tissue Res       Date:  1976-12-22

2.  Mitochondria and biological mineralization processes: an exploration.

Authors:  A L Lehninger
Journal:  Horiz Biochem Biophys       Date:  1977

Review 3.  Physicochemical aspects of urolithiasis.

Authors:  B Finlayson
Journal:  Kidney Int       Date:  1978-05       Impact factor: 10.612

Review 4.  Bone mineral on the molecular level.

Authors:  A S Posner
Journal:  Fed Proc       Date:  1973-09

Review 5.  A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth.

Authors:  H Fleisch; R G Russell
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

6.  Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation.

Authors:  J D Termine; R A Peckauskas; A S Posner
Journal:  Arch Biochem Biophys       Date:  1970-10       Impact factor: 4.013

7.  Adenylylimidodiphosphate and guanylylimidodiphosphate.

Authors:  R G Yount
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

8.  The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite.

Authors:  J L Meyer; G H Nancollas
Journal:  Calcif Tissue Res       Date:  1973-12-31

9.  The effect of imidodiphosphate (P-N-P) on the precipitation and dissolution of calcium phosphate in vitro.

Authors:  W G Robertson; H Fleisch
Journal:  Biochim Biophys Acta       Date:  1970-12-29

10.  A thermodynamic analysis of the secondary transition in the spontaneous precipitation of calcium phosphate.

Authors:  J L Meyer; E D Eanes
Journal:  Calcif Tissue Res       Date:  1978-08-18
View more
  15 in total

1.  Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships.

Authors:  S S Schwartz; D I Hay; S K Schluckebier
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

Review 2.  Calcium orthophosphates: crystallization and dissolution.

Authors:  Lijun Wang; George H Nancollas
Journal:  Chem Rev       Date:  2008-09-25       Impact factor: 60.622

3.  An Avrami analysis of the effects of serum and human albumin on calcium hydroxyapatite crystal growth.

Authors:  W M Mullins; C R Elsass
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

4.  Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

Review 5.  Interactions of polyamines with ion channels.

Authors:  K Williams
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

6.  Phosphate is a specific signal for induction of osteopontin gene expression.

Authors:  G R Beck; B Zerler; E Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  The effects of serum and human albumin on calcium hydroxyapatite crystal growth.

Authors:  J Garnett; P Dieppe
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

8.  Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite.

Authors:  S M Qiu; G Wen; N Hirakawa; R D Soloway; N K Hong; R S Crowther
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite.

Authors:  M Johnsson; C F Richardson; J D Sallis; G H Nancollas
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 10.  Hydroxyapatite deposition disease of the joint.

Authors:  Eamonn S Molloy; Geraldine M McCarthy
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.